- Home
- NVAX vs ODV Comparison
NVAX vs ODV Comparison
Compare NVAX & ODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVAX | ODV |
|---|---|---|
| Founded | 1987 | 2005 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | NVAX | ODV |
|---|---|---|
| Price | $6.75 | $3.77 |
| Analyst Decision | Hold | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $9.75 | N/A |
| AVG Volume (30 Days) | ★ 3.3M | 1.4M |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.07 | N/A |
| Revenue | ★ $1,064,651,000.00 | $8,089,655.00 |
| Revenue This Year | $58.91 | $102.54 |
| Revenue Next Year | N/A | $106.31 |
| P/E Ratio | $3.22 | ★ N/A |
| Revenue Growth | ★ 20.27 | N/A |
| 52 Week Low | $5.01 | $1.16 |
| 52 Week High | $11.55 | $4.21 |
Technical Indicators
Market Signals| Indicator | NVAX | ODV |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 56.64 |
| Support Level | $6.36 | $3.61 |
| Resistance Level | $6.76 | $4.21 |
| Average True Range (ATR) | 0.22 | 0.20 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 47.39 | 43.03 |
Price Performance
Historical ComparisonAbout NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About ODV Osisko Development Corp.
Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration, and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico, and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation, and development activities of its projects.